Kay Kinzie

Maternal Lopinavir/Ritonavir Is Associated with Fewer Adverse Events in Infants than Nelfinavir or Atazanavir

E. Barr, M. Levin, Jeri E. Forster, 2016, Infectious diseases in obstetrics and gynecology.

Birth Weight and Preterm Delivery Outcomes of Perinatally vs Nonperinatally Human Immunodeficiency Virus-Infected Pregnant Women in the United States: Results From the PHACS SMARTT Study and IMPAACT P1025 Protocol

M. McNichols, S. Bewley, W. Borkowsky, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Safety and Tolerability of Antiretrovirals during Pregnancy

E. Barr, M. Levin, A. Weinberg, 2011, Infectious diseases in obstetrics and gynecology.

Serious Adverse Events Are Uncommon with Combination Neonatal Antiretroviral Prophylaxis: A Retrospective Case Review

E. Barr, M. Levin, Jeri E. Forster, 2015, PloS one.

Kinetics and Determining Factors of the Virologic Response to Antiretrovirals during Pregnancy

E. Barr, M. Levin, C. Peloquin, 2010, Infectious diseases in obstetrics and gynecology.

Resistance to antiretrovirals in HIV-infected pregnant women.

E. Barr, M. Levin, A. Weinberg, 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Development and Implementation of an Interdisciplinary Model for the Management of Breastfeeding in Women With HIV in the United States: Experience From the Children's Hospital Colorado Immunodeficiency Program

E. Barr, Rebecca Lynn Johnson, A. Weinberg, 2023, Journal of acquired immune deficiency syndromes.

Safety and Tolerability of Antiretrovirals during Pregnancy

E. Barr, M. Levin, A. Weinberg, 2011, Infectious diseases in obstetrics and gynecology.